Talk to our team

Tell us about your organisation and we will reply within one business day.

Thank you. Your Submission Has Been Received!

Our team will be in touch shortly.

Oops! Something went wrong while submitting the form.
Vee Healthtek Horizontal Color logo

Ophthalmology revenue cycle performance for laterality, diagnostic evidence, and ophthalmic drug payment.

Two eye-specific encounter markers connect to separate claim rows, with the treated-eye drug pairing highlighted in orange.

7 of top 20

U.S. health systems served

32M+

Coding charts processed annually

28M+

A/R claims managed annually

WHY PARTNER

Route medical and vision benefits before eye-care services begin

Make interpretations and laterality support every diagnostic claim

Match intravitreal procedures with drug units and treated eye

WHAT WE DELIVER

Front-office

Mid-office

WHAT WE IMPACT

Correct benefit routing. Defensible test claims. Matched injection and drug reimbursement.

HOW WE DELIVER

Eye-care specialists, encounter intelligence, and governance for complex ophthalmic payment.

Expertise-led

Technology-powered

Operationally-governed

Our Vision

Open accountability: Taking responsibility without taking control.

Ophthalmology leaders retain control of clinical systems, payer policies, and care standards. We own agreed workflows and measures. Open Accountability connects benefit routing, authorization, laterality, interpretation completion, injection-drug matching, global-period logic, denials, and payment variance. Transparent encounter queues show where revenue risk entered and who must resolve it.

Open accountability — line illustration of a ring held open, its closing span carried in orange.

Medical-versus-vision routing

Coverage responsibility is correct before the encounter begins

Laterality accuracy

Reported eye matches documentation across tests and procedures

Interpretation completion

Diagnostic findings and reports reach billing without delay

Injection-to-drug claim match

Procedure, agent, units, wastage, and eye remain aligned

Ophthalmic drug variance recovery

Incorrect drug reductions reach evidence-based payer resolution

Why Us

Rework-Powered Cleanup Machine

Our First-Pass Performance

Medical and vision payer mismatch

Coverage errors surface after testing or claim rejection.

Benefit type and service purpose receive validation before scheduling.

Missing diagnostic interpretation

Tests bill before findings and reports support medical necessity.

Interpretation completion drives prebilling exception queues.

Incorrect treated-eye reporting

Laterality conflicts appear across procedure, diagnosis, and drug lines.

Encounter evidence drives consistent eye-specific claim construction.

Unmatched injection and drug

Procedure and ophthalmic drug lines move through separate queues.

Agent, units, wastage, and treated eye reconcile before submission.

Global-period modifier conflict

Second-eye or unrelated care denies inside an open surgical global.

Timing, eye, and clinical relationship guide modifier validation.

POINTS OF VIEW

Revenue cycle thinking for leaders who need fewer surprises.

Explore Vee Healthtek perspectives on the forces reshaping revenue cycle performance, healthcare operations, technology adoption, and financial resilience.

Trace where a diagnostic test, cataract case, or retina injection loses value.

Schedule a 30-minute working session with our ophthalmology revenue cycle lead. Bring one pressure point: benefit routing, test interpretation, laterality, cataract globals, drug units, or aged A/R. We will trace the encounter from scheduling through payment. Then we will identify first-pass controls that prevent repeat leakage.

Thank you. Your Submission Has Been Received!

Continue exploring expert perspectives, industry trends, and practical strategies for improving revenue cycle performance.

Explore Points Of View
Oops! Something went wrong while submitting the form.

Frequently Asked Questions

How should ophthalmology practices choose between eye codes and E/M codes?

White plus sign symbol on a transparent background.

What documentation supports OCT, visual fields, and fundus photography?

White plus sign symbol on a transparent background.

How do you reconcile intravitreal injections with ophthalmic drug claims?

White plus sign symbol on a transparent background.

How are cataract global periods and second-eye procedures billed correctly?

White plus sign symbol on a transparent background.

When is modifier 25 appropriate with an intravitreal injection?

White plus sign symbol on a transparent background.

Which KPIs reveal ophthalmology revenue leakage earliest?

White plus sign symbol on a transparent background.

Can support begin with cataract, retina, glaucoma, or diagnostic testing?

White plus sign symbol on a transparent background.